Elaina B.

Elaina B. is a highly experienced leader in pharmaceutical research and development, currently serving as Senior Director and Head of Preclinical and Translational Science at Amylyx Pharmaceuticals since July 2025, overseeing a diverse drug pipeline. Prior roles include Senior Director of Translational Development and SGT-501 Program Lead at Solid Biosciences, where responsibility encompassed gene therapy portfolio strategy and execution of preclinical studies. Elaina has also held positions at AavantiBio, Inc. and Exicure, focusing on gene therapy pipeline development, pharmacology, and program management. Educational credentials include a Ph.D. in Cell and Molecular Biology from the University of Michigan Medical School and a Bachelor of Science in Biological Sciences from Indiana University South Bend.